Deletion 1p at Time of Diagnosis of Multiple Myeloma Portends Inferior Outcomes

被引：1
|
作者：
Vaishnav, Arti [1 ]
Khan, Abdullah [2 ]
Zhao, Qiuhong [2 ]
Bumma, Naresh [3 ]
Cottini, Francesca [2 ]
Umyarova, Elvira [2 ]
Sharma, Nidhi [4 ]
Rosko, Ashley E. [2 ,5 ]
Benson, Don [2 ]
Devarakonda, Srinivas [2 ]
机构：
[1] Ohio State Univ, Coll Med, Columbus, OH USA
[2] Ohio State Univ, Columbus, OH USA
[3] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH USA
[4] Ohio State Univ, Div Hematol, Wexner Med Ctr, Columbus, OH USA
[5] Ohio State Univ, Div Hematol, Columbus, OH USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-182845
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Prognostic value of 1p deletion for multiple myeloma: a meta-analysis
    Ouyang, J.
    Gou, X.
    Ma, Y.
    Huang, Q.
    Jiang, T.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2014, 36 (05) : 555 - 565
  • [2] DELETION OF CDKN2C DRIVES THE PROGNOSTIC IMPACT OF DELETION 1P IN MULTIPLE MYELOMA
    Begum, D.
    Ellis, S.
    Price, A.
    Smith, C.
    Sherborne, A.
    Proszek, P.
    Johnson, D.
    Walker, B.
    Jones, J.
    Pawlyn, C.
    Jenner, M.
    Drayson, M.
    Owen, R.
    Houlston, R.
    Cairns, D.
    Gregory, W.
    Cook, G.
    Davies, F.
    Morgan, G.
    Jackson, G.
    Kaiser, M.
    HAEMATOLOGICA, 2016, 101 : 329 - 329
  • [3] Identification of Micro RNAs within Chromosome 1p Minimal Deletion Region Associated Adverse Outcomes in Multiple Myeloma
    Yang, Y.
    Ning, Y.
    Chang, H.
    MODERN PATHOLOGY, 2012, 25 : 382A - 382A
  • [4] Identification of Micro RNAs within Chromosome 1p Minimal Deletion Region Associated Adverse Outcomes in Multiple Myeloma
    Yang, Y.
    Ning, Y.
    Chang, H.
    LABORATORY INVESTIGATION, 2012, 92 : 382A - 382A
  • [5] Outcomes of Myeloma Patients with Deletion 1p Receiving Lenalidomide, Bortezomib, and Dexamethasone (RVD) Therapy
    Odikadze, Levani
    Joseph, Nisha
    Schmidt, Timothy M.
    Heffner, Leonard
    Hofmeister, Craig C.
    Dhodapkar, Madhav V.
    Gupta, Vikas A.
    Boise, Lawrence H.
    Jaye, David L.
    Lonial, Sagar
    Nooka, Ajay K.
    Kaufman, Jonathan L.
    BLOOD, 2018, 132
  • [6] 1p and 1q: Partners in crime in multiple myeloma
    Devarakonda, Srinivas S.
    Vaishnav, Arti
    Zhao, Qiuhong
    Bumma, Naresh
    Cottini, Francesca
    Sharma, Nidhi
    Umyarova, Elvira
    Rosko, Ashley Elizabeth
    Benson, Don M., Jr.
    Khan, Abdullah Mohammad
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [7] Moderate-Severe Thrombocytopenia Portends Poor Outcomes in Multiple Myeloma
    Ferri, Grace M.
    Yildirim, Cenk
    Park, Joseph
    Do, Nhan, V
    Brophy, Mary T.
    Munshi, Nikhil C.
    V. Edwards, Camille
    Fillmore, Nathanael R.
    BLOOD, 2024, 144 : 6930 - 6930
  • [8] Hereditary leiomyomatosis showing deletion of 1p in multiple lesions: a case report
    Sadiq, N.
    Hislop, G.
    Berg, J.
    Murray, E.
    Ragupathy, K.
    Christie, L.
    VIRCHOWS ARCHIV, 2020, 477 : S302 - S302
  • [9] DELETION OF CHROMOSOME 1P - A SHORT REVIEW
    HOWARD, PJ
    PORTEUS, M
    CLINICAL GENETICS, 1990, 37 (02) : 127 - 131
  • [10] Gain of chr1q Portends Poor Outcomes in Multiple Myeloma Patients Treated with Venetoclax
    Lagana, Alessandro
    Thibaud, Santiago
    Melnekoff, David T.
    Restrepo, Paula
    Leshchenko, Violetta
    McCafferty, Jonathan
    Newman, Scott
    Kern, Abbi
    Corrigan, David
    Hantash, Feras
    Rossi, Adriana
    Rodriguez, Cesar
    Sanchez, Larysa
    Richard, Shambavi
    Chari, Ajai
    Cho, Hearn J.
    Jagannath, Sundar
    Richter, Joshua
    Parekh, Samir
    BLOOD, 2022, 140 : 4388 - 4390
12345